Page last updated: 2024-10-27

fluconazole and Porphyria Cutanea Tarda

fluconazole has been researched along with Porphyria Cutanea Tarda in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Research Excerpts

ExcerptRelevanceReference
"A 53-yr-old man, known to have had AIDS for 6 months, developed the clinical signs and symptoms of porphyria cutanea tarda (PCT) preceding deterioration of his illness."1.28Porphyria cutanea tarda in a patient with AIDS. ( Lustermans, FA; Russel, MG; van Pelt, J; Wuite, J, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Russel, MG1
Lustermans, FA1
Wuite, J1
van Pelt, J1

Other Studies

1 other study available for fluconazole and Porphyria Cutanea Tarda

ArticleYear
Porphyria cutanea tarda in a patient with AIDS.
    The Netherlands journal of medicine, 1992, Volume: 41, Issue:1-2

    Topics: Acquired Immunodeficiency Syndrome; Anemia; Fluconazole; Humans; Male; Middle Aged; Porphyria Cutane

1992